Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Verona Pharma plc | 4,123,091 | reported | 15 May 2023 | tx 12+360,000−6,622,777 |
| Dimension Therapeutics, Inc. | 32,069 | reported | 19 May 2016 | tx 6+5,429,767−15,192,874 |
| ChemoCentryx, Inc. | 12,500 | reported | 22 Jun 2012 | tx 1+12,500 |
| Enliven Therapeutics, Inc. | 1,580 | reported | 12 Feb 2026 | tx 12+8,025,523−1,035,425 |
| Turnstone Biologics Corp. | 0 | reported | 08 Aug 2025 | tx 9+3,137,575−5,781,864 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 Feb 2026 | GRANT_AWARD | Enliven Therapeutics, Inc. | 1,580 | 0.00 USD | deriv |
| 12 Feb 2026 | GRANT_AWARD | Enliven Therapeutics, Inc. | 33,989 | 0.00 USD | deriv |
| 08 Aug 2025 | TENDER | Turnstone Biologics Corp. | 3,099,265 | — | |
| 06 Feb 2025 | GRANT_AWARD | Enliven Therapeutics, Inc. | 20,491 | 0.00 USD | deriv |
| 03 Jun 2024 | GRANT_AWARD | Turnstone Biologics Corp. | 12,770 | 0.00 USD | deriv |
| 16 May 2024 | SALE | Enliven Therapeutics, Inc. | 33,300 | 22.14 USD | |
| 16 May 2024 | SALE | Enliven Therapeutics, Inc. | 1,000,000 | 22.14 USD | |
| 13 Feb 2024 | GRANT_AWARD | Enliven Therapeutics, Inc. | 16,835 | 0.00 USD | deriv |
| 16 Oct 2023 | GRANT_AWARD | Turnstone Biologics Corp. | 25,540 | 0.00 USD | deriv |
| 20 Jul 2023 | CONVERSION | Turnstone Biologics Corp. | 2,682,599 | — | |
| 20 Jul 2023 | PURCHASE | Turnstone Biologics Corp. | 416,666 | 12.00 USD | first after silence |
| 20 Jul 2023 | CONVERSION | Turnstone Biologics Corp. | 1,249,829 | — | deriv |
| 20 Jul 2023 | CONVERSION | Turnstone Biologics Corp. | 266,240 | — | deriv |
| 20 Jul 2023 | CONVERSION | Turnstone Biologics Corp. | 229,158 | — | deriv |
| 20 Jul 2023 | CONVERSION | Turnstone Biologics Corp. | 937,372 | — | deriv |
| 17 May 2023 | EXERCISE | Enliven Therapeutics, Inc. | 2,125 | 4.28 USD | |
| 17 May 2023 | EXERCISE | Enliven Therapeutics, Inc. | 2,125 | 0.00 USD | deriv |
| 11 May 2023 | SALE | Verona Pharma plc | 80,000 | 22.26 USD | |
| 12 May 2023 | SALE | Verona Pharma plc | 43,200 | 21.64 USD | |
| 15 May 2023 | SALE | Verona Pharma plc | 14,400 | 21.96 USD | |
| 15 May 2023 | SALE | Verona Pharma plc | 345,313 | 20.00 USD | |
| 28 Apr 2023 | GRANT_AWARD | Verona Pharma plc | 96,000 | 0.00 USD | deriv |
| 23 Feb 2023 | GRANT_AWARD | Enliven Therapeutics, Inc. | 27,567 | 0.00 USD | deriv |
| 23 Feb 2023 | GRANT_AWARD | Enliven Therapeutics, Inc. | 7,611,458 | — | |
| 23 Feb 2023 | GRANT_AWARD | Enliven Therapeutics, Inc. | 288,114 | — |
1 purchase reported after at least 12 months of silence — most recent on 20 Jul 2023.